266 related articles for article (PubMed ID: 34453786)
21. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
22. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
[TBL] [Abstract][Full Text] [Related]
23. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
[TBL] [Abstract][Full Text] [Related]
24. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV).
Wongyanin P; Buranapraditkun S; Chokeshai-Usaha K; Thanawonguwech R; Suradhat S
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):170-82. PubMed ID: 19709757
[TBL] [Abstract][Full Text] [Related]
25. Increased frequency and FOXP3 expression of human CD8
Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
[TBL] [Abstract][Full Text] [Related]
26. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
27. CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases.
Moon HW; Kim BH; Park CM; Hur M; Yun YM; Kim SY; Lee MH
Korean J Lab Med; 2011 Oct; 31(4):231-7. PubMed ID: 22016675
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of regulatory T cells (CD4+CD25+Foxp3+) correlates with tumor stage in patients with colorectal cancer.
Bacić D; Uravić M; Bacić R; Sutić I; Petrosić N
Coll Antropol; 2011 Sep; 35 Suppl 2():65-8. PubMed ID: 22220406
[TBL] [Abstract][Full Text] [Related]
29. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.
Clarke SL; Betts GJ; Plant A; Wright KL; El-Shanawany TM; Harrop R; Torkington J; Rees BI; Williams GT; Gallimore AM; Godkin AJ
PLoS One; 2006 Dec; 1(1):e129. PubMed ID: 17205133
[TBL] [Abstract][Full Text] [Related]
30. FOXP3 and CD25 double staining antibody cocktails identify regulatory T cells in different types of tumor tissues using tissue microarrays.
Liu X; Wang X; Ding J; Gao Y; Zhao Y; Zhao R; Sun Q; Zhang S
Ann Diagn Pathol; 2019 Feb; 38():67-70. PubMed ID: 30502715
[TBL] [Abstract][Full Text] [Related]
31. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma.
Rissetto KC; Rindt H; Selting KA; Villamil JA; Henry CJ; Reinero CR
Vet Immunol Immunopathol; 2010 May; 135(1-2):137-145. PubMed ID: 20197202
[TBL] [Abstract][Full Text] [Related]
32. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
[TBL] [Abstract][Full Text] [Related]
33. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
34. Tim3
Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
[TBL] [Abstract][Full Text] [Related]
35. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
[TBL] [Abstract][Full Text] [Related]
36. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.
Klein S; Kretz CC; Krammer PH; Kuhn A
J Invest Dermatol; 2010 Feb; 130(2):492-9. PubMed ID: 19940860
[TBL] [Abstract][Full Text] [Related]
37. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
38. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
39. Cytokine profile of CD4
Niakan A; Faghih Z; Talei AR; Ghaderi A
Mol Immunol; 2019 Dec; 116():90-97. PubMed ID: 31630080
[TBL] [Abstract][Full Text] [Related]
40. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]